Morgan Stanley Trims Price Target on Merck to $115 From $116, Maintains Equalweight Rating

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: – sale of pharmaceutical products (87.8%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; – sale of vaccines (19.9%); – sale of animal health products (11.4%); – other (0.8%). Net sales are distributed geographically as follows: the United States (46%), Europe/Middle East/Africa (27.4%), China (9%), Japan (5.6%), Asia/Pacific (4.9%), Latin America (4.5%) and other (2.6%).